• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Novavax’s Updated COVID Vaccine Candidate Neutralizes Emerging Subvariants

cafead

Administrator
Staff member
  • cafead   Aug 22, 2023 at 11:52: PM
via Novavax’s vaccine candidate against new sublineages of COVID-19 is showing promising results in small animal and non-human primate studies. The company announced Tuesday that its XBB COVID vaccine candidate induced neutralizing antibody responses in the EG.5.1 and XBB.1.16.6 subvariants, dubbed Eris and Fornax, respectively.

article source
 

<